SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001193125-22-153170
Filing Date
2022-05-17
Accepted
2022-05-17 17:30:01
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-4 d638476ds4.htm S-4 411648
2 EX-5.1 d638476dex51.htm EX-5.1 15477
3 EX-23.1 d638476dex231.htm EX-23.1 1862
4 EX-25 d638476dex25.htm EX-25 94793
5 EX-99.1 d638476dex991.htm EX-99.1 94025
6 EX-FILING FEES d638476dexfilingfees.htm EX-FILING FEES 29199
7 GRAPHIC g638476dsp99.jpg GRAPHIC 10726
8 GRAPHIC g638476g00a03.jpg GRAPHIC 35828
9 GRAPHIC g638476g0514022804877.jpg GRAPHIC 77668
10 GRAPHIC g638476g0514022805049.jpg GRAPHIC 76006
11 GRAPHIC g638476new.jpg GRAPHIC 315251
  Complete submission text file 0001193125-22-153170.txt   1353330
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-265023 | Film No.: 22936048
SIC: 2836 Biological Products, (No Diagnostic Substances)